In order to maximize brand value and exceed peak year sales forecasts, specialty biotechnology companies must do everything they can to identify patients, remove barriers to treatment, and maximize adherence. Given the limited patient populations addressed by many modern therapies, organizations must maximize the value of each patient. The most successful organizations are now using a technology-first approach, focusing more on data and analytics to drive strategic planning and tactical execution across their commercial teams, improving efficiency and effectiveness across sales, marketing, and market access.

In this webinar, we'll highlight some of these approaches and demonstrate how data and analytics can be used to gain a competitive advantage and create differentiation.

Featured Speakers

Frank Lane

VP of Solution Architecture
SHYFT, a Medidata Company

Frank is a results-driven leader who combines deep life sciences domain expertise and operational excellence to lead cross-functional teams that deliver customer-first solutions. Frank has designed, built, deployed, and managed data management and business intelligence solutions for clients ranging from mid-tier Pharma to blockbuster status across a number of specialty and retail markets.

Vincent Marino

Director of Strategic Development
SHYFT, a Medidata Company

Vincent Marino is Director of Strategic Development at SHYFT, a Medidata company. He has spent the majority of his career helping biotech companies successfully commercialize specialty medicines through use of data and analytics.


Register now for this webinar